Division 1.2.3

United Kingdom

Quinolones

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues
Danofloxacin	Danofloxacin	Bovine	200 μg/kg	Muscle
		Not for use in animals from which milk is produced for human consumption	100 μg/kg	Fat
			400 μg/kg	Liver
			400 μg/kg	Kidney
		Chicken	200 μg/kg	Muscle
		Not for use in animals from which eggs are produced for human consumption	100 μg/kg	Skin and fat
			400 μg/kg	Liver
			400 μg/kg	Kidney
Difloxacin	Difloxacin	Chicken, turkey	300 μg/kg	Muscle
			400 μg/kg	Skin and fat
			1 900 μg/kg	Liver
			600 μg/kg	Kidney
Enrofloxacin	Sum of enrofloxacin and ciprofloxacin	Bovine	100 μg/kg	Muscle
			100 μg/kg	Fat
			300 μg/kg	Liver
			200 μg/kg	Kidney
			100 μg/kg	Milk
		Rabbits	100 μg/kg	Muscle
			100 μg/kg	Fat
			200 μg/kg	Liver
			300 μg/kg	Kidney
		Porcine	100 μg/kg	Muscle
			100 μg/kg	Skin and fat
			200 μg/kg	Liver
			300 μg/kg	Kidney
		Poultry	100 μg/kg	Muscle
		Not for use in animals from which eggs are produced for human consumption	100 μg/kg	Skin and fat
			200 μg/kg	Liver
			300 μg/kg	Kidney
Sarafloxacin	Sarafloxacin	Chicken	10 μg/kg	Skin and fat
			100 μg/kg	Liver
		Salmonidae	30 μg/kg	Muscle and skin in natural proportions